Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

Clinical trial NCT05898399 · RECRUITING

Trial details

NCT number: NCT05898399
Sponsor: Artios Pharma Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2023-06-30
Primary completion: 2028-06-30
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.